XML 44 R25.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS' EQUITY (DEFICIT) (Tables)
 6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Share-Based Payment Arrangement, Cost by Plan
The following tables present the Company's total share based compensation expense by award type for the three and six months ended June 30, 2023 and 2022:

(In thousands)Three Months Ended
June 30,		Six Months Ended
June 30,
2023202220232022
RSUs$5,536 $4,902 $11,638 $8,252 
Performance RSUs2,300 1,500 4,232 1,500 
Options1,376 2,208 3,494 4,393 
Total Share Based Compensation Expense$9,212 $8,610 $19,364 $14,145 
Schedule of Computation of Income (Loss) per Share
(In thousands, except per share data)Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
NUMERATOR:    
Net income (loss) attributable to the Company – common shares$(884,470)$14,401 $(1,106,730)$(34,181)
DENOMINATOR(1):
   
Weighted average common shares outstanding - basic149,179 148,050 148,774 147,783 
  Stock options and restricted stock(2):
— 1,081 — — 
Weighted average common shares outstanding - diluted149,179 149,131 148,774 147,783 
Net income (loss) attributable to the Company per common share:   
Basic$(5.93)$0.10 $(7.44)$(0.23)
Diluted$(5.93)$0.10 $(7.44)$(0.23)
(1) All of the outstanding Special Warrants are included in both the basic and diluted weighted average common shares outstanding of the Company for the three and six months ended June 30, 2023 and 2022.
(2) Outstanding equity service awards representing 13.8 million and 6.2 million shares of Class A common stock of the Company for the three months ended June 30, 2023 and 2022, respectively, and $12.7 million and $10.4 million for the six months ended June 30, 2023 and 2022 respectively, were not included in the computation of diluted earnings per share because to do so would have been antidilutive.